CHRISTOPHER JOHN KENNEY

Insider Reports History

Location
Burnaby,
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CHRISTOPHER JOHN KENNEY:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Chief Medical Officer Common Shares 4,729 $284,250 $60.11 10 Mar 2026 Direct
Xenon Pharmaceuticals Inc. Chief Medical Officer Share Option (Right to Buy) 100,000 09 Jan 2026 Direct
Xenon Pharmaceuticals Inc. Chief Medical Officer Restricted Share Units 20,000 09 Jan 2026 Direct
Xenon Pharmaceuticals Inc. Chief Medical Officer Performance Share Units 0 09 Mar 2026 Direct

Insider Reports Filed by CHRISTOPHER JOHN KENNEY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XENE Xenon Pharmaceuticals Inc. 09 Mar 2026 4 -$166,559 4 Chief Medical Officer 11 Mar 2026, 19:21
XENE Xenon Pharmaceuticals Inc. 09 Jan 2026 2 $0 4 Chief Medical Officer 09 Jan 2026, 18:54
XENE Xenon Pharmaceuticals Inc. 12 Mar 2025 2 $0 4 Chief Medical Officer 13 Mar 2025, 19:31
XENE Xenon Pharmaceuticals Inc. 11 Mar 2024 1 $0 4 Chief Medical Officer 12 Mar 2024, 18:38
XENE Xenon Pharmaceuticals Inc. 24 Mar 2023 1 -$24,507 4 Chief Medical Officer 24 Mar 2023, 19:18
XENE Xenon Pharmaceuticals Inc. 10 Mar 2023 1 $0 4 Chief Medical Officer 14 Mar 2023, 16:32
XENE Xenon Pharmaceuticals Inc. 10 Mar 2022 1 $0 4 Chief Medical Officer 14 Mar 2022, 16:13
XENE Xenon Pharmaceuticals Inc. 21 Jan 2022 1 +$20,167 4 Chief Medical Officer 21 Jan 2022, 16:04
XENE Xenon Pharmaceuticals Inc. 23 Aug 2021 1 $0 4 Chief Medical Officer 25 Aug 2021, 16:12
XENE Xenon Pharmaceuticals Inc. 23 Aug 2021 0 $0 3 Chief Medical Officer 25 Aug 2021, 16:05